2van der Werf MJ, Venema K. Bifidobacteria: genetic modification and the study of their role in the colon. J Agric Food Chem, 2001,49: 378-383.
3Satokari RM, Vaughan EE, Akkermans AD,et al. Bifidobacterial diversity in human feces detected by genus-specific PCR and denaturing gradient gel electrophoresis. Appl Environ Microbiol, 2001, 67:504-513.
4Elmer GW. Probiotics: living drugs. Am J Health Syst Pharm, 2001,58 : 1101-1109.
5Requena T,Burton J, Matsuki T, et al. Identification, detection, and enumeration of human bifidobacterium species by PCR targeting the transaldolase gene. Appl Environ Microbiol, 2002,68:2420-2427.
6Ventura M, Reniero R, Zink R. Specific identification and targeted characterization of Bifidobacterium lactis from different environmental isolates by a combined multiplex-PCR approach. Appl Environ Microbiol, 2001,67: 2760-2765.
7Fandi KG, Ghazali HM, Yazid AM, et al. Purification and Nterminal amino acid sequence of fructose-6-phosphate phosphoketolase from Bifidobacterium longum BB536. Lett Appl Microbiol, 2001,32: 235-239.
8Lee KY, So JS, Heo TR. Thin layer chromatographic determination of organic acids for rapid identification of bifidobacteria at genus level. J Microbiol Methods,2001, 45:1-6.
9Tanaka H, Hashiba H, Kok J, et al. Bile salt hydrolase of Bifidobacterium longum-biochemical and genetic characterization. Appl Environ Microbiol, 2000,66: 2502-2512.
10Yazid AM,Ali AM,Shuhaimi M, et al. Antimicrobial susceptibility of bifidobacteria. Lett Appl Microbiol,2000,31:57-62.
1Uronis JM,Mühlbauer M,Herfarth HH,et al.Modulation of the intestinal microbiota alters colitis-associated colorectal cancer susceptibility.PLoS One,2009,4:e6026.
2Uronis JM,Jobin C.Microbes and colorectal cancer:is there a relationship? Curr Oncol,2009,16:22-24.
3Bibiloni R,Fedorak RN,Tannock GW,et al.VSL# 3 probiotic-mixture induces remission in patients with active ulcerative colitis.Am J Gastroenterol,2005,100:1539-1546.
4Jobin C.Probiotics and ileitis:could augmentation of TNF/NFBactivity be the answer? Gut Microbes,2010,1:196-199.
5Bai AP,Ouyang Q.Probiotics and inflammatory bowel diseases.Postgrad Med J,2006,82:376-382.
6Lee JW,Shin JG,Kim EH,et al.Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum.J Vet Sci,2004,5:41-48.
7de Moreno de LeBlanc A,Perdigón G.Reduction of betaglucuronidase and nitroreductase activity by yoghurt in a murine colon cancer model.Biocell,2005,29:15-24.
8Ferguson LR,Philpott M,Karunasinghe N.Dietary cancer and prevention using antimutagens.Toxicology,2004,198:147-159.
9Zsivkovits M,Fekadu K,Sontag G,et al.Prevention of heterocyclic amine-induced DNA damage in colon and liver of rats by different lactobacillus strains.Carcinogenesis,2003,24:1913-1918.
10Lim CC,Ferguson LR,Tannock GW.Dietary fibres as "prebiotics":implications for colorectal cancer.Mol Nutr Food Res,2005,49:609-619.
